Dr Halpern was most recently director of regulatory affairs and head of technical regulatory affairs, North America for GlaxoSmithKline Biologicals.
Dr Halpern has received her bachelor’s degree in physiology from University of California at Davis and her doctorate in pharmacology from the University of Rochester.
Robert Paull, co-founder and CEO of Genocea, said: “Jane’s pharma industry and governmental regulatory experience, combined with her knowledge of the FDA vaccine review process, is invaluable to our company. She understands both US and European regulatory pathways and her strong track record at bringing vaccines into the clinic and through the approval process will help Genocea accelerate its path to market.”